ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 727487 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 727487; 2) Community: the network communities that were significantly associated with the response to NSC 727487; 3) Molecule: the relationships between components within communities and NSC 727487; 4) MDR: the compounds that were significantly associated with the NSC 727487.

NSC Compound Enrichment Correlation
NSC 732962 5-amino-4-(1,3-benzothiazol-2-yl)-1-(2-chloro-5-trifluoromet hylphenyl)-2,3-dihydro-1H-3-pyrrolone 0.0392716453377535 0.36105105
NSC 735472 (2E,8S,9Z)-2,9,16-heptadecatrien-4,6-diyn-1,8-diol 0.0392716453377535 0.34703597
NSC 744023 (11aS)-8-(3-{4-[(E)-3-(2-hydroxyphenyl)-3-oxo-1-propenyl]-2-methoxyphenoxy}propoxy)-7-methoxy-2,3,5,11a-tetrahydro-1H-benzo[e]pyrrolo[1,2-a][1,4]diazepin-5-one 0.0392716453377535 0.27500093
NSC 752761 Null 0.0392716453377535 -0.055910381
NSC 755880 Mitomycin (USAN) 0.0392716453377535 0.13983147
NSC 756375 GW811761X 0.0392716453377535 -0.08574907
NSC 100880 Camptothecin 0.0403978426119736 0.16142711
NSC 105014 Cladribine 0.0403978426119736 0.19329469
NSC 148790 Card-20(22)-enolide, 16-(acetyloxy)-3,14-dihydroxy-, (3.beta.,5.beta.,16.beta.)- (9CI) 0.0403978426119736 0.25876445
NSC 163424 4-Quinazolinamine, 2-[2-(1-pyrrolidinylazo)phenyl]- 0.0403978426119736 0.33948043
Total:59  Current:51    [First] [Prev] [Next] [Last]